Sensitization of prostate cancer to radiation therapy: Molecules and pathways to target

Sensitization of prostate cancer to radiation therapy: Molecules and pathways to target.

Full text not available from this repository.
Item Type: Article
Status: Published
Official URL: https://doi.org/10.1016/j.radonc.2018.05.021
Journal or Publication Title: Radiotherapy and Oncology
Volume: 128
Number: 2
Page Range: pp. 283-300
Date: 2018
Divisions: Immune Imaging
Depositing User: General Admin
Identification Number: 10.1016/j.radonc.2018.05.021
ISSN: 01678140
Date Deposited: 04 Jan 2021 04:55
Abstract:

Radiation therapy is used to treat cancer by radiation-induced DNA damage. Despite the best efforts to eliminate cancer, some cancer cells survive irradiation, resulting in cancer progression or recurrence. Alteration in DNA damage repair pathways is common in cancers, resulting in modulation of their response to radiation. This article focuses on the recent findings about molecules and pathways that potentially can be targeted to sensitize prostate cancer cells to ionizing radiation, thereby achieving an improved therapeutic outcome.

Creators:
Creators
Email
Yao, Mu
UNSPECIFIED
Rogers, Linda
UNSPECIFIED
Suchowerska, Natalka
UNSPECIFIED
Choe, Daniel
UNSPECIFIED
Al-Dabbas, Mahmoud A.
UNSPECIFIED
Narula, Ramit S.
UNSPECIFIED
Lyons, J. Guy
UNSPECIFIED
Sved, Paul
UNSPECIFIED
Li, Zhong
UNSPECIFIED
Dong, Qihan
UNSPECIFIED
Last Modified: 04 Jan 2021 04:55
URI: https://eprints.centenary.org.au/id/eprint/610

Actions (login required)

View Item View Item